Singapore markets closed

Regeneron Pharmaceuticals, Inc. (REGN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
1,063.60-3.66 (-0.34%)
At close: 04:00PM EDT
1,083.00 +19.40 (+1.82%)
After hours: 07:53PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
13,100,100
13,117,200
12,172,900
16,071,700
8,497,100
Cost of revenue
1,792,100
1,815,800
1,560,400
2,437,500
1,119,900
Gross profit
11,308,000
11,301,400
10,612,500
13,634,200
7,377,200
Operating expenses
Research development
4,586,200
4,439,000
3,592,500
2,860,100
2,735,000
Selling general and administrative
2,719,200
2,631,300
2,115,900
1,824,900
1,346,000
Total operating expenses
7,319,100
7,068,200
5,618,500
4,639,400
3,800,600
Operating income or loss
3,988,900
4,233,200
4,994,000
8,994,800
3,576,600
Interest expense
71,100
73,000
59,400
57,300
56,900
Total other income/expenses net
-438,000
-456,800
-235,900
342,500
290,700
Income before tax
4,042,000
4,199,300
4,858,800
9,325,800
3,810,400
Income tax expense
184,200
245,700
520,400
1,250,500
297,200
Income from continuing operations
3,857,800
3,953,600
4,338,400
8,075,300
3,513,200
Net income
3,857,800
3,953,600
4,338,400
8,075,300
3,513,200
Net income available to common shareholders
3,857,800
3,953,600
4,338,400
8,075,300
3,513,200
Basic EPS
37.37
37.05
40.51
76.40
32.65
Diluted EPS
35.06
34.77
38.22
71.97
30.52
Basic average shares
106,800
106,700
107,100
105,700
107,600
Diluted average shares
113,800
113,700
113,500
112,200
115,100